tiprankstipranks
Advertisement
Advertisement

SLXN Stock Latest News

Silexion Therapeutics files to sell 859,609 ordinary shares for holders
The FlySilexion Therapeutics files to sell 859,609 ordinary shares for holders
7d ago
SLXN
Silexion Therapeutics Implements 1-for-10 Reverse Share Split
PremiumCompany Announcements
Silexion Therapeutics Implements 1-for-10 Reverse Share Split
21d ago
8K
SLXN
Silexion Therapeutics Corp trading halted, news pending
PremiumThe Fly
Silexion Therapeutics Corp trading halted, news pending
22d ago
SLXN
Silexion Therapeutics announces 1-for-10 reverse share split
PremiumThe Fly
Silexion Therapeutics announces 1-for-10 reverse share split
24d ago
SLXN
Silexion Therapeutics Announces Reverse Split to Maintain Listing
PremiumCompany Announcements
Silexion Therapeutics Announces Reverse Split to Maintain Listing
24d ago
8K
SLXN
3 Penny Stocks to Watch Now, 5/21/26
PremiumMarket News3 Penny Stocks to Watch Now, 5/21/26
29d ago
HCWB
MTVA
Silexion Therapeutics Announces Warrant Inducement Financing Agreement
Premium
Company Announcements
Silexion Therapeutics Announces Warrant Inducement Financing Agreement
1M ago
8K
SLXN
Silexion Announces Positive Preclinical Data for SIL204 Therapy
Premium
Company Announcements
Silexion Announces Positive Preclinical Data for SIL204 Therapy
1M ago
8K
SLXN
Silexion Therapeutics initiates GMP clinical batch manufacturing of SIL204
PremiumThe Fly
Silexion Therapeutics initiates GMP clinical batch manufacturing of SIL204
1M ago
SLXN
Silexion Advances SIL204 With Manufacturing and Trial Approval
PremiumCompany Announcements
Silexion Advances SIL204 With Manufacturing and Trial Approval
1M ago
8K
SLXN
Silexion Therapeutics Shareholders Approve Capital Increase, Reverse Split
PremiumCompany Announcements
Silexion Therapeutics Shareholders Approve Capital Increase, Reverse Split
1M ago
8K
SLXN
Silexion Therapeutics submits SIL204 clinical trial application to Germany
PremiumThe Fly
Silexion Therapeutics submits SIL204 clinical trial application to Germany
2M ago
SLXN
Silexion advances SIL204 to EU Phase 2/3 pancreatic trial
PremiumCompany AnnouncementsSilexion advances SIL204 to EU Phase 2/3 pancreatic trial
2M ago
8K
SLXN
Silexion Therapeutics Announces Immediate Board Membership Change
Premium
Company Announcements
Silexion Therapeutics Announces Immediate Board Membership Change
3M ago
8K
SLXN
Silexion Therapeutics approved to initiate Phase 2/3 clinical trial of SIL204
Premium
The Fly
Silexion Therapeutics approved to initiate Phase 2/3 clinical trial of SIL204
3M ago
SLXN
Silexion gains approval for SIL204 pancreatic cancer trial
PremiumCompany Announcements
Silexion gains approval for SIL204 pancreatic cancer trial
3M ago
8K
SLXN
Silexion Shareholders Reject Capital Increase and Plan Amendments
PremiumCompany Announcements
Silexion Shareholders Reject Capital Increase and Plan Amendments
3M ago
8K
SLXN
Silexion Therapeutics urges shareholders to vote ahead of EGM
PremiumThe Fly
Silexion Therapeutics urges shareholders to vote ahead of EGM
4M ago
SLXN
Silexion Therapeutics is developing a potential “holy grail” play in precision oncology (NASDAQ: SLXN)
PremiumTipRanks Newswire
Silexion Therapeutics is developing a potential “holy grail” play in precision oncology (NASDAQ: SLXN)
4M ago
SLXN
Silexion Highlights SIL204 RNAi Pancreatic Cancer Program Progress
PremiumCompany AnnouncementsSilexion Highlights SIL204 RNAi Pancreatic Cancer Program Progress
5M ago
8K
SLXN
Silexion outlines 2026 plans after transformational 2025 progress
Premium
Company Announcements
Silexion outlines 2026 plans after transformational 2025 progress
5M ago
8K
SLXN
Silexion Therapeutics issues letter to shareholders
Premium
The Fly
Silexion Therapeutics issues letter to shareholders
5M ago
SLXN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >